Yes, $.02 even, Nice 90% up day. Where do we go from here?

will the price hold $.02?

I have been looking to add but the low volume has been a challenge. Now that we are seeing a pullback, I hesitate due to needed financing and how that will effect pps.

PPS driven down to 2013 Levels.

Hundreds of millions of dollars spent and now partners and running for the door.

The last 7 years have not proven kind to shareholders. Dr. Kim has accumulated cheap shares and salary, and so far we have nothing to show for it.

You could see the mismanagement starting in 2014: not partnering VGX-3100, huge burn rate, dumping huge amounts of shares on the market to depress any pps gains.

We he or we live long enough to see anything but losses for this company?

So if $.007 is the magic number, I'll spend some pocket change on a few more shares. Let's see if anyone is willing to sell shares lower than that.

Trying to remain positive, but someone seems to have an unlimited amount of shares and is willing to part with them at .007.

Holding what I have, but the company has to show some positive news, or realize they don't need the funds if it means selling shares at .007.

Small add today 50k at .0121.

Sorry now that I only picked up an additional 25k yesterday at $.02.
282k and counting

Don't doubt that some dilution is still going on to hold down the price. I do agree, that the float is mostly held by longer term investors, not selling here.

So far today, $6,000 in shares traded have dropped the pps from $.034 to .028, with barely a half a million shares traded.

Holding for the long-term, since these short term price fluctuations have little influence on the long term outlook here. IMHO

Looking for opportunities to buy more here.

VNDM on the Ask at .0325

If the PPS stays here it's more opportunities for me to accumulate. Only one thing that could ruin the good fortune is huge dilution from sales and/or authorized shares released from financing, which will ultimately end up with another reverse. yesterdaysnews74



Agree 100%.

Added 50K at .0252 yesterday. Have been here on and off, mostly on, and have seen the pps drop to an unexpected level. This is a great product and it looks like the world is waking up to it. I hope the U.S. also sees the benefit here in this country.

scubastevemd-

I guess I haven't been doing this as long as you have, but I agree with most of the comments you made, regarding investing/trading small medical and biotech stocks.
Some of the things working against the longs and for the shorts:

Time
Funds
Regulatory
Management execution
Clinical trial execution and outcomes ( only a fraction of treatments make it to Phase 3)
Biotechs PPS drop as a group, but don't always rise that way.

I few investors/traders find a way to make money long, but most of the little guys are ill-informed to do so, in this sector. Find a system that works or follow someone that has a strategy that has worked long term. It can be done.

Long VCEL, but wondering with this approved technology, why we see very little PPS movement.

http://investorshub.advfn.com/uimage/uploads/2016/12/13/wlwhjimage.jpg

How about $.27?

I hope after a while rationale people will stop being scared and afraid of everything, including their shadow.
One thing that will be different from the current administration and the incoming one, is that the incoming administration has respect for the "rule of law". Even though some in the new administration may not like MJ legalization, in some states, they will most likely respect these laws and the will of the voters.

Therefore Mr. Sessions opinions will have little effect on XXII pps.
My question is: when can we expect any positive movement here?

From what I am hearing, Andexanet alfa will be approved next week.

Just a matter of how much of a bounce we see.

52 week Range: $18.20 to $57.96.

219K shares on the ask at $.328

I see no reason to expect that Heplisav will not get approved by Sept. 15, 2016.

Of course there was not good reason it was not approved the last time it came before the FDA.

When asked about the potential market share that a Dynavax vaccine could achieve, Dr. Balagopal, assistant professor of medicine at the Johns Hopkins University School of Medicine, said that the size of the market likely wouldn’t change much, but Dynavax could potentially take over the vast majority of the current market.

Current Worldwide market for Hep B Vaccines: $1 Billion

Current price: $21.50

DVAX pps should move up substantially in the next six months.

Just having a hard time trying to figure the price action of the last few weeks. Then again, I guess, why should I be trying.

Whether the run up to $11.80 was deserved on not, the two week reversal to $6.55 was surely not justified by anything attributable to NVIV. Some profit taking, yes, but a 40% shave. It seems to draw your attention.

A restatement of the company status and direction this week by the CEO, but it was mostly the same information as was provided two weeks ago. A positive article by "The Street" and NVIV is up over 13%? No ATM pressure today?

Let's see where we go from here. I think I will just sit back and watch for awhile.

On the other hand $1.73 might have been a buying opportunity.

Reports Q3 (Sep) loss of $0.05 per share, $0.01 worse than the single analyst estimate of ($0.04); revenues rose 73.9% year/year to $4 mln vs the $2.4 mln single analyst estimate.
Reports 50% sequential quarterly and 168% year-over-year third quarter Lymphoseek product sales growth.

NAVB closed 8% higher than that low of the day, what makes you think we are headed to $1.25?

I don't see anything in the Q3 2015 Financial results that would shave 36% off the pps.

Early Promise for a New Paralysis Treatment

http://finance.yahoo.com/news/early-promise-paralysis-treatment-221357079.html

NAVB has held up very well considering the drop in the IBB recently.

Most days you can count on a "paint job" that drops the pps by at least $.01.

If that is the way you feel, my advice to you is to sell all shares immediately.

I on the other hand, will keep mine awhile longer, since I see nothing but positives ahead and see no reason to sell or be worried in the slightest.

Since the 5th patient was enrolled in the trial 10 days ago, we have seen the pps solidly in the $10.50 range, except for the buying opportunity on Sept 14.

Volume is down, but with so many potential catalysts coming in the near future, I believe we will see less of an effort to drive the pps downward.

News will take the pps toward previous highs, and for those patient longs, they will see their patience and DD payoff.

Buyers that have been on the sidelines, with this news and direction from the company are now trying to get their shares, creating a little buying pressure.

In all likelihood the shares are not going to continue straight up, but I like the progression of the trial, and the plans the company has to move the scaffold forward.

I think we are going to see more buying.

Appreciate your article/post evaluating the status and potential of NVIV.

No one has challenged the benefit shown, in the first 3 patients, and other than the pace of trial and the ATM, a reason for the sell off. Of course, IMHO, those items, by themselves should not have caused this retracement. They just happened to occur doing a time that biotechs and the market as a whole have undergone a correction.

I am holding and adding to my position here. Looking for a rebound, particularly once the overall market stabalizes.

If we've seen the downward pressure with no news, with this news we should see pps start to recover and continue higher with patient 5.

Would have been nice to pull the trigger on a few shares yesterday!

pistol1p Friday, 08/08/14 09:18:43 PM
Re: leakdog post# 19936
Post # of 32038
Yes, let's go back to the beginning of this 3 year old company.

How far it has come in 3 years and how much potential that hopefully is about to be realized.

I will state that Punit is one of the best biotech CEO's, if he can return the pps back to what is was 3 years ago: $1.50. I think he and his staff can do it, therefore I am holding my shares long for at least that moment.

Fair enough?

ONCS

4 year ago PPS, split adjusted: $30.00
1 year ago, on the date of the original post, pps $8.80
Yesterday PPS $4.91

When do we see a reversal in this trend and do any changes need to be made within the company to achieve a reversal?

I tend to be a very patient investor, but I need to see something positive, from time to time, to give me some confidence in this company.

OFF TOPIC, Are you Serious?

The link includes analyst information on NVIV.

This link was posted by "BioHunter" on another board.

http://www.thelifesciencesreport.com/pub/na/16724?utm_source=delivra&utm_medium=email&utm_campaign=TLSR+final+7-29-15

No published buy yet by Sheff, but .......

$heff Member Level Tuesday, 07/28/15 03:48:10 PM
Re: $heff post# 89189
Post # of 89340
$RXII..$.44 starting to look like a potential swing trade here. Definitely on watch!! Catalysts in Q3 & Q4 could give it a nice bump.

NVIV pps is up 25% from the R/S price of April 8th.

I was a buyer in today's trading, as I expect the pps to go higher, if the news continues positive. Shares today on sale for approx. 10% off yesterday's close.

A majority of my shares are held for the long-term, so today's price action does not concern me and allows me to add both to my long-term and short-term investment here.

Nice close over $17 pps.

Making our way back up to the upper $17's and just waiting for news of newly enrolled patients or updates on the currently enrolled.

All has been positive so far, and I am expecting that to continue.

Volume is relatively low as I think most shareholders and shares are looking for the longer term payoff.

As anyone that follows Sheff, he can get out of a position as quickly as he entered.

Not saying that's what will happen, but don't be surprised.

Good luck to all the longs here.

I picked up a few shares here, thinking maybe PPHM can't stay down forever.

But I always did like to take a chance on long expected potential, once in a while.

PPHM Returns:

10 yr = -76%
5 yr = -27%
2 yr = -10.5%
1 yr = -27%

Some "investors" have been waiting a long time for some positive return on their investment.

PATIENCE to the daily pps fluctuations.

Know what you own, do your DD.

Buy the dips:

07/07/2015 Buy Trade Details NVIV
INVIVO THERAPEUTICS
250 $15.61

Adding to an over-weighted position

Had a buy order in at $15.43, that didn't trip in another account.

Current price near $17.00 up about 8% from the LOD.

PATIENCE, Buy the dips

Anybody that is a buyer is a welcome addition to the board.

Nice day for the longs, almost up 10%.

"Took a 1500 share position this morning. $NVIV"

Welcome Canoepaddler!